Valquest Partners

Valquest Partners, founded in 2013 and based in Beirut, Lebanon, is an asset manager focused on identifying, structuring, investing in, and actively managing operating assets in Europe and the MENA region. The firm utilizes the extensive financial, operational, transactional, and industry experience of its partners to enhance its investment strategies. Valquest Partners aims to optimize asset performance through a hands-on approach, ensuring that investments are well-managed and aligned with market opportunities.

Fadi Noureddine

Co-Founder and Managing Partner

Walid Sfeir

Co-Founder and Managing Partner

3 past transactions

Bloom Biorenewables

Series A in 2025
Bloom Biorenewables Ltd is a Swiss company established in 2019, specializing in the development of innovative technologies that convert wood and agricultural waste into renewable materials as substitutes for petroleum-based products. The company focuses on producing bio-based materials for various sectors, including fragrances, plastics, and textiles, thereby offering sustainable alternatives to fossil fuels. By introducing a novel approach to the production of biorenewable products and fuels, Bloom Biorenewables aims to make a significant impact in promoting the use of sustainable resources and addressing climate change challenges.

TISSIUM

Series B in 2019
TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.

Afyren

Venture Round in 2019
Afyren is a sustainable chemistry company focused on developing innovative biotechnological solutions that utilize non-food biomass to replace petroleum-based ingredients. Committed to environmental sustainability, Afyren employs natural microorganisms to produce a range of bio-sourced organic acids and a high-value fertilizer. The company's approach aligns with the principles of a circular, low-carbon economy, emphasizing the valorization of biomass while minimizing environmental impact. Through its advancements, Afyren aims to contribute to the transition toward greener and more sustainable industrial practices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.